Company: SMNR
Filing Date: 2025-05-15
Form Type: NT 10-Q
Source: 0001213900-25-044260
Chunk: 1

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-05-15
Form: NT 10-Q
Chunk 1
---
 will be filed on or before the fifth      
 calendar day following the prescribed due date; and                                                                                       |

| (c) | The                                                                                                 
 accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |

PART III – NARRATIVE

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q,
10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

Denali Capital Acquisition Corp. (the “Registrant”) is
unable, without unreasonable effort or expense, to file its Quarterly Report on Form 10-Q for the period ended March 31, 2025 (the “Quarterly
Report”) within the prescribed filing date of May 15, 2025, due to a delay experienced by the Registrant in completing its financial
statements and other disclosures in the Quarterly Report. As a result, the Registrant is still in the process of compiling required information
to complete the Quarterly Report for the quarter ended March 31, 2025, to be incorporated in the Quarterly Report. The Registrant anticipates
that it will file the Quarterly Report no later than the fifth calendar day following the prescribed filing date.

PART IV – OTHER INFORMATION

| (1) | Name and telephone number of person to contact in regard to this notification |

| Lei Huang |     |        646 |     | 978-5180          |
| (Name)    |     | -Area Code |     | -Telephone Number |

| (2) | Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). Yes ☒ No ☐ |

| (3) | Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? Yes ☐ No ☒ |

<div align='center'>2

Denali Capital Acquisition Corp.

(Name of registrant as Specified in Charter)</div>

has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.

| Date: